期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
糖链抗原19-9放免测定对诊断胃肠道潜隐癌的价值 被引量:10
1
作者 赵双罗 刘东刚 +2 位作者 李建国 张波壮 杨华 《中国肿瘤临床》 CAS CSCD 北大核心 1995年第5期312-314,共3页
对胃肠道潜隐癌、癌前病变和炎性病变各30例患者术前的糖链抗原(CA)19-9水平进行回顾性分析,发现3组之间或两两比较均有明显差异。发现<37u/ml者97.44%为良性病变,>90u/ml者94.44%为恶性病变。... 对胃肠道潜隐癌、癌前病变和炎性病变各30例患者术前的糖链抗原(CA)19-9水平进行回顾性分析,发现3组之间或两两比较均有明显差异。发现<37u/ml者97.44%为良性病变,>90u/ml者94.44%为恶性病变。37~90u/ml之间者复查前后对比,癌变组血清CA19-9水平平均升高14.42u/ml,良性病变组平均下降9.62u/ml。提示对经内镜活组织检查未被证实的可疑胃肠道肿瘤患者,常规CA19-9放免测定有助于发现胃肠道潜隐癌。 展开更多
关键词 CA19-9 放免测定 胃肠道肿瘤 潜隐癌
下载PDF
胃潜隐癌 被引量:2
2
作者 赵双罗 任朝英 贾冬梅 《临床消化病杂志》 1997年第1期11-12,共2页
对我院1974年~1994年经术后病理证实的胃潜隐癌202例进行了回顾分析,结果表明该癌占同期胃癌的8.88%,并呈逐年下降趋势(P<0.005)。本组癌多为进展期(96.04%),以弥漫型浸润型为多(63.86%),癌灶以胃体底部多见(55.99%),... 对我院1974年~1994年经术后病理证实的胃潜隐癌202例进行了回顾分析,结果表明该癌占同期胃癌的8.88%,并呈逐年下降趋势(P<0.005)。本组癌多为进展期(96.04%),以弥漫型浸润型为多(63.86%),癌灶以胃体底部多见(55.99%),内镜活检结果以坏死组织和慢性炎症占多数(75.25%)。认识到潜隐癌的这些特点,采取相应的综合诊断措施,可使该癌的诊断进一步降低。 展开更多
关键词 潜隐癌 综合诊断
原文传递
Asymptomatic colonic metastases from primary squamous cell carcinoma of the lung with a positive fecal occult blood test 被引量:1
3
作者 Shoji Hirasaki Seiyuu Suzuki +3 位作者 Shigeki Umemura Haruhito Kamei Masato Okuda Kenichiro Kudo 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第35期5481-5483,共3页
We describe a 74-year-old man with a colonic metastatic squamous cell carcinoma (SCC) from the lung. His chest X-ray revealed an abnormal shadow in the right upper lobe. Computed tomography (CT) of the chest demonstra... We describe a 74-year-old man with a colonic metastatic squamous cell carcinoma (SCC) from the lung. His chest X-ray revealed an abnormal shadow in the right upper lobe. Computed tomography (CT) of the chest demonstrated a large lung tumor in the right upper lobe obstructing the right upper bronchus. Bronchoscopy revealed an easy-bleeding tumor in the right upper bronchus that was diagnosed as poorly differentiated squamous cell lung carcinoma. He underwent colonoscopy because he had a positive fecal occult blood test. Colonoscopy revealed a large protruding lesion with central ulceration in the descending colon. Histological examination of the biopsy specimen obtained from the colonic lesion revealed SCC. The lesion was diagnosed as metastatic colonic SCC. He had no abdominal symptoms. He underwent chemotherapy with an infusion of cisplatin 130 mg i.v. day 1, and docetaxel hydrate 100 mg i.v. day 1, repeated every 4 wk, followed by 4 courses of chemotherapy. The primary lesion shrank by less than 10% and was judged to be "Partial Response" (PR) after 3 courses of treatment. The patient still lived 23 wk after the diagnosis of metastatic colonic SCC. Colonic metastasis of primary SCC of the lung is rare. 展开更多
关键词 Gastrointestinal metastatic tumor Colonic metastasis Large intestine COLONOSCOPY Chemotherapy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部